Rock Springs Capital Management’s Vera Therapeutics VERA Stock Holding History

Rock Springs Capital Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.3M	Sell	427,584 -76,001	-15%	-$2.83M	0.9%	37
2026 Q1	$20.3M	Sell	503,585 -64,994	-11%	-$2.8M	1.19%	26
2025 Q4	$28.8M	Sell	568,579 -48,817	-8%	-$1.73M	1.48%	22
2025 Q3	$17.9M	Hold	617,396	–	–	1.05%	32
2025 Q2	$14.5M	Buy	617,396 +96,600	+19%	+$2.17M	0.91%	40
2025 Q1	$12.5M	Buy	520,796 +32,933	+7%	+$1.06M	0.72%	47
2024 Q4	$20.6M	Buy	487,863 +104,371	+27%	+$4.62M	0.79%	44
2024 Q3	$17M	Buy	383,492 +2,300	+0.6%	+$87.3K	0.55%	52
2024 Q2	$13.8M	Buy	381,192 +40,024	+12%	+$1.59M	0.42%	60
2024 Q1	$14.7M	Buy	+341,168	New	+$12.2M	0.37%	67

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Rock Springs Capital Management's VERA Position: Q2 2026 in Review

Rock Springs Capital Management reduced its Vera Therapeutics (VERA) stake by 15% in Q2 2026, selling an estimated $2.83M and leaving 427,584 shares worth $18.3M. The position accounts for 0.9% of the portfolio, ranked #37.

Rock Springs Capital Management first reported a position in VERA in Q1 2024 and has held it in 10 quarters since. The position peaked at $28.8M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Rock Springs Capital Management held 427,584 shares of Vera Therapeutics worth $18.3M as of Q2 2026.
Rock Springs Capital Management sold 76,001 Vera Therapeutics shares in Q2 2026, an estimated $2.83M.
Vera Therapeutics made up 0.9% of Rock Springs Capital Management's portfolio in Q2 2026, its #37 holding.
Rock Springs Capital Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 10 quarters since.
Rock Springs Capital Management's Vera Therapeutics position peaked at $28.8M in Q4 2025.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.